Main Article Content
Underweight, older children and adolescents, oral nutritional supplementation (ONS), anthropometric assessment, Insulin-like growth factor 1 (IGF1).
Abstract. Objectives: This controlled trial investigated the effects of energy-dense pediatric oral nutritional supplements ONS versus standard ONS in pediatric patients requiring oral nutritional support for low body mass index (BMI) or weight gain per day (WGD) below the average for age and sex. Patients and Methods: 34 children and adolescents (mean age 10.2 years) with faltering growth requiring ONS were randomized to cONS (n =22) or sONS (n = 12) for a year. We recorded their weight (WT), height (HT) and calculated height growth velocity (GV), Ht-SDS, BMI, WGD, every 3 months for a year. Results: The WGD, height growth velocity (GV: cm/year), and Ht-SDS increased significantly, in both groups, during the year of ONS. The use of the cONS resulted in significantly greater mean total WGD and BMI-SDS after 6 months and 1 year, compared to the sONS group. The increase in IGF1-SDS was significantly higher in the cONS groups versus the sONS group. Moreover, the WGD was correlated significantly with the height GV during the year of ONS intake. Conclusions: ONS improved the growth of underweight old children and adolescents who had no systemic illness. There was a significantly higher WGD and BMI-SDS in the group on cONS compared to those on sONS. In both groups, long-term use of ONS significantly improved Ht-SDS.
2. Shields B, Wacogne I, Wright CM. Weight faltering and failure to thrive in infancy and early childhood. BMJ. 2012; 345: e5931.
3. United Nations Children’s Fund (UNICEF), World Health Organization (WHO), World Bank. Levels and trends in child malnutrition: key findings of the 2018 edition of the joint child malnutrition estimates. New York, Geneva, Washington, DC: UNICEF, WHO, The World Bank, 2018.
4. Black RE, Victora CG, Walker SP, Bhutta ZA, Christian P, de Onis M, et al. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet 2013; 382:427–51.
5. de Onis M, Branca F. Childhood stunting: a global perspective. Matern Child Nutr 2016; 12:12–26.
6. Dewey KG, Begum K. Long-term consequences of stunting in early life. Matern Child Nutr 2011; 7:5–18.
7. Bundy DAP, de Silva N , Horton S, Patton GC, Schultz L, Jamison D T. Child and Adolescent Health and Development: Realizing Neglected Potential.In: Disease Control Priorities (third edition): Volume 8, Child and Adolescent Health and Development, edited by Bundy D A P, Silva N de, Horton S, Jamison D T, Patton G C, editors. . Washington, DC: World Bank, 2017.
8. Caulfield L E, Elliot V. Nutrition of Adolescent Girls and Women of Reproductive Age in Low- and Middle-Income Countries: Current Context and Scientific Basis for Moving Forward. Arlington, VA: USAID/Strengthening Partnerships, Results, and Innovations in Nutrition Globally (SPRING) Project, 2015.
9. WHO (World Health Organization). Global Prevalence of Anaemia. WHO, Geneva, Switzerland, 2011.
10. WHO (World Health Organization). Supplementary Foods for the Management of Moderate Acute Malnutrition in Infants and Children 6–59 Months of Age. Technical Note, WHO, Geneva, Switzerland, 2012.
11.Brown B, Roehl K, Betz M. Enteral nutrition formula selection: current evidence and implications for practice. Nutr Clin Pract. 2015; 30:72-85.
12. Kral TV, Rolls BJ. Energy density and portion size: their independent and combined effects on energy intake. Physiol Behav.2004; 82:131–8.
13. Hubbard GP, EliaM, Holdoway A, Stratton RJ. A systematic review of compliance to oral nutritional supplements. Clin Nutr.2012; 31293–312.
14. WHO. WHO Child Growth Standards: Length/Height-for-Age, Weight-for-Age,Weight-for Length, Weight-for-Height and Body Mass Index-for-Age: Methods and Development,WHO, Geneva, Switzerland, 2006.
15. King C, Davis T.Nutritional treatment of infants and children with faltering growth. Eur J Clin Nutr. 2010; 64 (Suppl 1): S11–3.
16. Hubbard GP, Elia M, Holdoway A, Stratton RJ. A systematic review of compliance to oral nutritional supplements. Clin Nutr. 2012;31:293-312.
17. Hubbard GP, Fry C, Sorensen K, Casewell C, Collins L, Cunjamalay A, et al. Energy-dense, low-volume paediatric oral nutritional supplements improve total nutrient intake and increase growth in paediatric patients requiring nutritional support: results of a randomised controlled pilot trial. Eur J Pediatr. 2020; 179:1421-30.
18. Fatima S, Malkova D, Wright C, Gerasimidis K. Impact of therapeutic food compared to oral nutritional supplements on nutritional outcomes in mildly underweight healthy children in a low-medium income society. Clin Nutr. 2018; 37:858-63.
19. Huynh DT, Estorninos E, Capeding MR, Oliver JS, Low YL, Rosales FJ. Impact of long-term use of oral nutritional supplement on nutritional adequacy, dietary diversity, food intake and growth of Filipino preschool children. J Nutr Sci. 2016;5: e20.
20. Huynh DT, Estorninos E, Capeding RZ, Oliver JS, Low YL, Rosales FJ.Longitudinal growth and health outcomes in nutritionally at-risk children who received long-term nutritional intervention. J Hum Nutr Diet.2015; 28, 623–35.
21. Galaa SZ. Relationships between Wasting and Stunting and Their Concurrent Occurrence in Ghanaian Preschool Children. J Nutr Metab. 2016; 2016:4654920. doi:10.1155/2016/4654920.
22. Brown KH, Black RE, Becker S. Seasonal changes in nutritional status and the prevalence of malnutrition in a longitudinal study of young children in rural Bangladesh. Am J Clin Nutr. 1982;36:303-13.
23. Nabarro D, Howard P, Cassels C, Pant M, Wijga A, Padfield N.The importance of infections and environmental factors as possible determinants of growth retardation in less-developed countries. Vevey: Nestle Nutrition/New York: Worksop series volume 14, Raven Press,1988.
24. Clemmons DR. Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes. Endocrinol Metab Clin North Am. 2012; 41:425-43.
25. Kuemmerle JF. Insulin-like growth factors in the gastrointestinal tract and liver. Endocrinol Metab Clin North Am. 2012; 41:409-23.
26. Hong H, Cui ZZ, Zhu L, Fu SP, Rossi M, Cui YH, Zhu BM. Central IGF1 improves glucose tolerance and insulin sensitivity in mice. Nutr Diabetes. 2017; 7:2.
27. De Ita JR, Castilla-Cortázar I, Aguirre GA, Sánchez-Yago C, Santos-Ruiz MO, Guerra-Menéndez L, et al. Altered liver expression ofgenes involved in lipid and glucose metabolism in mice with partial IGF-1 deficiency: an experimental approach to metabolic syndrome. J Transl Med. 2015; 13:326.
28. Bortvedt SF, Lund PK. Insulin-like growth factor 1: common mediator of multiple enterotrophic hormones and growth factors. Curr Opin Gastroenterol. 2012; 28:89-98.
29. Pérez R, Castilla-Cortázar I, Núñez M, Prado A, Mirpuri E, Garcia M, et al. IGF-I does not improve fat malabsorption in cirrhotic rats. J Physiol Biochem. 2001;57: 59–60.
30. Houle VM, Park YK, Laswell SC, Freund GG, Dudley MA, Donovan SM. Investigation of Three Doses of Oral Insulin-like Growth Factor-I on Jejunal Lactase Phlorizin Hydrolase Activity and Gene Expression and Enterocyte Proliferation and Migration in Piglets. Pediatr Res.2000; 48:497–503.
31. Wang DD, Sun M, Wang X, Cheng YY. Changes in serum levels of IGF-1, ghrelin and nesfatin-1 and clinical significance after treatment with recombinant human growth hormone in children with idiopathic short stature. J Biol Regul Homeost Agents. 2019; 33:1759-63.
32.Högler W, Briody J, Moore B, Lu PW, Cowell CT. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency. Bone. 2005; 37:642-50.
33. Underwood LE, Thissen JP, Lemozy S, Ketelslegers JM, Clemmons DR. Hormonal and nutritional regulation of IGF-I and its binding proteins. Horm Res. 1994;42:145-51.